Recent Quotes
My Watchlist
Indicators
Hydroworld Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

West Pharmaceutical Services, Inc. Common Stock (NY:WST)

278.54 -6.32 (-2.22%)
Official Closing Price Updated: 7:00 PM EDT, Oct 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about West Pharmaceutical Services, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
West Pharmaceutical Services (WST) Stock Is Up, What You Need To Know
Shares of healthcare products company West Pharmaceutical Services (NYSE:WST) jumped 3.1% in the afternoon session after a research note from KeyBanc Capital Markets indicated positive momentum in the... 
Via StockStory
Topics Artificial Intelligence Supply Chain
Top S&P500 movers in Wednesday's session
Curious about the S&P500 stocks that are in motion on Wednesday? Join us as we explore the top movers within the S&P500 index during today's session. 
Via Chartmill
Life Sciences Tools & Services Stocks Q2 Teardown: PacBio (NASDAQ:PACB) Vs The Rest
As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the life sciences tools & services industry, including PacBio (NASDAQ:PACB) and its... 
Via StockStory
Topics Artificial Intelligence Economy
1 Cash-Heavy Stock Worth Your Attention and 2 We Question
A surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth. Some of these companies also face challenges like stagnating revenue, declining... 
Via StockStory
Topics Economy
3 Mid-Cap Stocks That Concern Us
Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from... 
Via StockStory
Topics Economy
Life Sciences Tools & Services Stocks Q2 Results: Benchmarking Illumina (NASDAQ:ILMN)
As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the life sciences tools & services industry, including Illumina (NASDAQ:ILMN) and its... 
Via StockStory
Topics Artificial Intelligence Economy
1 S&P 500 Stock on Our Watchlist and 2 Facing Challenges
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some... 
Via StockStory
Topics Economy Stocks
Q2 Earnings Highs And Lows: 10x Genomics (NASDAQ:TXG) Vs The Rest Of The Life Sciences Tools & Services Stocks
Wrapping up Q2 earnings, we look at the numbers and key takeaways for the life sciences tools & services stocks, including 10x Genomics (NASDAQ:TXG) and its peers. 
Via StockStory
Topics Artificial Intelligence Economy
Q2 Earnings Recap: West Pharmaceutical Services (NYSE:WST) Tops Drug Development Inputs & Services Stocks
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at drug development inputs & services stocks,... 
Via StockStory
Topics Economy
What's going on in today's session: S&P500 movers
Stay informed about the performance of the S&P500 index in the middle of the day on Tuesday. Uncover the top gainers and losers in today's session for valuable insights. 
Via Chartmill
1 of Wall Street’s Favorite Stock on Our Watchlist and 2 We Brush Off
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional... 
Via StockStory
Topics Economy Electric Vehicles
1 Healthcare Stock on Our Watchlist and 2 We Find Risky
Personal health and wellness is one of the many secular tailwinds for healthcare companies. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, and over the past six... 
Via StockStory
Topics Economy Stocks
3 Overrated Stocks That Fall Short
Exciting developments are taking place for the stocks in this article. They’ve all surged ahead of the broader market over the last month as catalysts such as new products and positive media coverage... 
Via StockStory
Topics Economy
Thermo Fisher, Baker Hughes And IQVIA Holdings Are Among Top 10 Large Cap Gainers Last Week (July 21-July 25): Are The Others In Your Portfolio?
Medpace, ICON, and West Pharma led last week's large-cap rally, driven by strong earnings beats and upgraded guidance. 
Via Benzinga
Topics Earnings
Top S&P500 movers in Friday's session
Let's delve into the developments on the US markets one hour before the close of the markets on Friday. Below, you'll find the top gainers and losers within the S&P500 index during today's session. 
Via Chartmill
Explore the top gainers and losers within the S&P500 index in today's session.
Let's delve into the developments on the US markets in the middle of the day on Friday. Below, you'll find the top gainers and losers within the S&P500 index during today's session. 
Via Chartmill
What's going on in today's session: S&P500 gap up and gap down stocks
Looking for the S&P500 stocks that are experiencing notable gaps on Friday? Find out which stocks are gapping up and gapping down in the S&P500 index during today's session. 
Via Chartmill
WST Q2 Deep Dive: High-Value Product Momentum Drives Guidance Increase
Healthcare products company West Pharmaceutical Services (NYSE:WST) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 9.2% year on year to $766.5 million. The... 
Via StockStory
Topics World Trade
Explore the top gainers and losers within the S&P500 index in today's session.
Curious about the top performers within the S&P500 index one hour before the close of the markets on Thursday? Dive into the list of today's session's top gainers and losers for a comprehensive... 
Via Chartmill
West Pharma EPS Jumps 22 Percent in Q2
Via The Motley Fool
12 Health Care Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session.
Curious about which S&P500 stocks are generating unusual volume on Thursday? Find out below. 
Via Chartmill
Why Are West Pharmaceutical Services (WST) Shares Soaring Today
Shares of healthcare products company West Pharmaceutical Services (NYSE:WST) jumped 22.9% in the afternoon session after the company reported strong second-quarter 2025 financial results and raised... 
Via StockStory
Topics Lawsuit Supply Chain
These S&P500 stocks are moving in today's session
Let's have a look at the top S&P500 gainers and losers in the middle of the day of today's session. 
Via Chartmill
Crude Oil Rises Over 1%; Alphabet Earnings Top Estimates
 
Via Benzinga
RPM International Posts Better-Than-Expected Earnings, Joins ICON, MaxLinear, Nasdaq And Other Big Stocks Moving Higher On Thursday
 
Via Benzinga
West Pharma Lifts Outlook On Surging GLP-1 Demand, Stock Soars
West Pharmaceutical raised its 2025 EPS and sales guidance after Q2 earnings and revenue topped estimates, fueled by strong demand for high-value products. 
Via Benzinga
These S&P500 stocks are gapping in today's session
Let's take a look at the S&P500 stocks that are experiencing notable price gaps in today's session on Thursday. Discover the gap up and gap down stocks in the S&P500 index. 
Via Chartmill
Thursday's session: gap up and gap down stocks
Today's session on Thursday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session. 
Via Chartmill
West Pharma Catapults, Making A Bullish Move, On Unexpectedly Strong Earnings
The company also raised its outlook for the year following a first-quarter setback in February. 
Via Investor's Business Daily
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.